Insulin glulisine and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Insulin glulisine and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin Glulisine
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glulisine-Rituximab Intravenous
- Insulin glulisine-Riva-Amoxicillin
- Insulin glulisine-Rivaroxaban
- Insulin glulisine-Rivastigmine
- Insulin glulisine-Rivastigmine Capsules
- Insulin glulisine-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Glulisine (Cartridges and Pens)
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin Glulisine (Vials)
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin glulisine Subcutaneous
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin human inhaled Inhalation
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin human regular Injection
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Insulin inhalation